You just read:

Regulus to Present Preclinical Efficacy Data Highlighting Potential of Novel Treatment for Nonalcoholic Steatohepatitis at The International Liver Congress™ 2019

News provided by

Regulus Therapeutics Inc.

Apr 08, 2019, 08:00 ET